Research and Markets has announced the addition of the "Indian
Diagnostic Services Market Outlook 2020" report to their
offering.
According to the new research report Indian Diagnostic Services
Market Outlook 2020, the diagnostic services market is expected to
continue growing at 27.5% for next five years. This growth is
likely to be driven by improving healthcare facilities, medical
diagnostic and pathological laboratories, private-public projects,
and the health insurance sector. Moreover, with the rise in health
consciousness in the society and the rising burden of chronic
diseases, this market will swell to approximately INR 860 Billion
in revenues market by 2020.
This present report provides an overview of the Indian
diagnostic lab services market delivering an effective overview of
the market size and future forecast. In terms of services, the
market is dominated by pathology services, which account for
approximately 70% of the market. The report additionally
investigates the current market trends and opportunities with their
impact on the performance of the sector. Further, the report
provides consumer behavior patterns with respect to diagnostic
services. Moreover, the report also provides insights regarding the
prevalence and incidences of various diseases for which the
diagnostic services are widely used.
The report also covers various business models in the Indian
diagnostic services market, which generally scale up the level of
diagnostic services and facilitate the entry of new market players.
The report effectively assesses the implementation of commonly used
models, such as PPP model, hub and spoke models, and even analyzes
their impact in generating revenue. Moreover, industry experts
prudently analyzed the regulatory and accreditation landscape with
respect to setting up of diagnostic labs in Indian cities. The
report, in this context, investigates into the viability of
accrediting such diagnostics labs.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. India: Macro and Demographic Indicators
3.1 Healthcare Spending
3.2 Healthcare Infrastructure
3.3 Huge Population Base
4. Market Dynamics
4.1 Drivers
4.1.1 Rising Demand of Preventive Care Diagnostics
4.1.2 Rising Burden of Chronic Diseases
4.1.3 Public - Private Partnership Models for Promoting
Diagnostic Services
4.1.4 Increasing Disposable Income
4.2 Challenges
4.2.1 Low Adoption of Advanced In-Vitro Diagnostic
Technologies
4.2.2 Lack of Proper Regulatory Framework
4.3 Opportunities
4.3.1 Increasing Investment by Foreign Companies
4.3.2 Rise in Medical Tourism
4.3.3 Tele-radiology: Prospective Service Facilitator for Remote
Areas
4.3.4 Emerging Tier II and Tier III cities
4.4 Trends
4.4.1 Increasing Automation Driving the Indian Diagnostic
Services Market
4.4.2 Inclination of Doctors towards Debt Financing
4.4.3 Home Care Health Accessibility: Gaining Consumer
Acceptance
4.4.4 E-packages: New Way to Deliver Diagnostic Services
4.4.5 Gene Based Testing Methods on the Rise
5. Disease Burden
5.1 Cancer
5.2 Cardiovascular Diseases
5.3 Tuberculosis
5.4 Malaria
5.5 HIV/AIDS
5.6 Diabetes Mellitus
5.7 Dengue
6. Diagnostic Services Market: Current and Future Analysis
6.1 Pathology Services
6.2 Radiology Services
7. Diagnostic Services Market: Opportunity Assessment
7.1 Diagnostics Laboratories: Urban and Rural Split
7.2 Cost Assessment of Tests: Tier I and Tier II
7.3 PE Investment Landscape
8. Diagnostic Services: Business Models
8.1 Public Private Partnership (PPP)
8.1.1 Understanding of Concept: Indian Scenario
8.1.2 PPP Model in Healthcare and Diagnostic Services
8.1.3 Key Healthcare and Diagnostics PPP Projects
8.1.4 Case Study
8.2 Single Specialty Model (SSM)
8.2.1 Understanding the Concept: Indian Scenario
8.2.2 Model's Key Advantages
8.2.3 Case Study
8.3 Hub and Spoke Model
8.3.1 Understanding of Concept: Indian Scenario
8.3.2 Model's Key Advantages
8.3.3 Case Study
9. Consumer Behavior Research in Tier I and II
9.1 Tier I: Spending Aggressively on Diagnostic Tests
9.2 Physicians' Referred Labs Given Highest Preference
9.3 Brand Popularity: Key Determinant for Lab Preference
9.4 Independent Labs: Popular Among Respondents
9.5 Private Lab Facilities Dominating Government Owned
Centers
9.6 Medium Scale Labs: Current Choice of the Respondents
10. Regulatory Environment: Accreditation and Quality
Assurance
10.1 Requirements for the Shop and Establishment Act
10.2 NABL Accreditation Mandates
10.3 NABL Accreditation Procedure
10.4 Plausible Impact of the Clinical Establishments Act,
2010
11. Competitive Landscape (Business Overview, and
Strength-Weakness Analysis)
11.1 Super Religare Laboratories
11.2 Dr. Lal PathLabs
11.3 Metropolis Healthcare Limited
11.4 Thyrocare Technologies Limited
11.5 Quest Diagnostics India Private Limited,
11.6 PathCare Labs Pvt. Ltd.
11.7 Oncquest Laboratories Ltd.
For more information visit
http://www.researchandmarkets.com/research/5pp56v/indian_diagnostic
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160530005234/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Diagnostics